ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 100 filers reported holding ANTARES PHARMA INC in Q2 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $99,000 | -59.1% | 30,000 | -62.5% | 0.00% | 0.0% |
| Q1 2019 | $242,000 | -31.6% | 80,000 | -38.5% | 0.00% | -50.0% |
| Q4 2018 | $354,000 | +31.6% | 130,000 | +62.5% | 0.00% | +100.0% |
| Q3 2018 | $269,000 | -19.7% | 80,000 | -38.5% | 0.00% | -50.0% |
| Q2 2018 | $335,000 | +17.1% | 130,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $286,000 | +10.4% | 130,000 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $259,000 | -38.5% | 130,000 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $421,000 | +0.5% | 130,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $419,000 | +84.6% | 130,000 | +62.5% | 0.00% | +100.0% |
| Q1 2017 | $227,000 | +845.8% | 80,000 | +607.3% | 0.00% | – |
| Q2 2015 | $24,000 | – | 11,310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 1,671,956 | $5,384,000 | 3.43% |
| ARMISTICE CAPITAL, LLC | 5,700,000 | $18,354,000 | 2.34% |
| Rubric Capital Management LP | 3,188,600 | $10,267,000 | 2.12% |
| Broadfin Capital, LLC | 4,803,528 | $15,467,000 | 1.88% |
| THOMPSON DAVIS & CO., INC. | 192,734 | $621,000 | 1.00% |
| Asymmetry Capital Management, L.P. | 199,655 | $643,000 | 0.76% |
| Perceptive Advisors | 4,267,253 | $13,741,000 | 0.69% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 946,987 | $3,049,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $886,000 | 0.20% |
| EAM Investors, LLC | 251,619 | $810,000 | 0.13% |